Frontline ponatinib plus hyper-CVAD over imatinib in adults with Ph-positive acute lymphoblastic leukemia: real-world efficacy and risks of early ponatinib dose reduction
Authors
Sanghyeun Park (ORCID: https://orcid.org/0009-0007-7914-2587)
Kyoung Il Min (ORCID: https://orcid.org/0000-0002-8089-3800)
S Lee
Hee-Je Kim
Jae-Ho Yoon
Seok-Goo Cho
Silvia Park
Ki-Seong Eom
Gi-June Min
Chang-Ki Min
Daehun Kwag
Byung-Sik Cho
Yoo-Jin Kim
Institutions
Ewha Womans University (KR)
The Catholic University of Korea Seoul St. Mary's Hospital (KR)
Frontline ponatinib plus hyper-CVAD over imatinib in adults with Ph-positive acute lymphoblastic leukemia: real-world efficacy and risks of early ponatinib dose reduction
Sanghyeun Park, Kyoung Il Min, S Lee, Hee-Je Kim et al.
Journal
Haematologica
Topics
Chronic Myeloid Leukemia Treatments
article
Frontline ponatinib plus hyper-CVAD over imatinib in adults with Ph-positive acute lymphoblastic leukemia: real-world efficacy and risks of early ponatinib dose reduction
Sanghyeun Park, Kyoung Il Min, S Lee, Hee-Je Kim, Jae-Ho Yoon, Seok-Goo Cho, Silvia Park, Ki-Seong Eom, Gi-June Min, Chang-Ki Min, Daehun Kwag, Byung-Sik Cho, Yoo-Jin Kim
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Ewha Womans University (KR), The Catholic University of Korea Seoul St. Mary's Hospital (KR), Catholic University of Korea (KR)